你好,请登录   免费注册    |    收藏本站
联系电话: 0574-87917803
联系电话: call_new 0574-87917803
T84.66A3.1A.1F2 [T84.66.A3.1-H-11]
T84.66A3.1A.1F2 [T84.66.A3.1-H-11]
规格:
货期:
编号:TS210794
品牌:Testobio
产品名称: T84.66A3.1A.1F2 T84.66.A3.1-H-11
商品货号: TS210794
Organism: Mus musculus (B cell); Mus musculus (myeloma), mouse (B cell); mouse (myeloma)
Cell Type: hybridoma: B lymphocyte
Product Format: frozen
Morphology: lymphoblast
Culture Properties: suspension, with some loosely adherent cells
Biosafety Level: 1

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Disease: Carcinoma
Applications:
The antibody reacts with CEA with an affinity constant of 2.6 X 10 exp10 l/m.
The antibody reacts strongly a variety of human carcinomas and moderately with human colonic polyps.
It cross-reacts weakly with granulocytes.
Storage Conditions: liquid nitrogen vapor phase
Disclosure: This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC.
Derivation:
Animals were immunized with purified CEA.
Spleen cells were fused with Sp2/0-Ag14 myeloma cells.
Genes Expressed:
immunoglobulin; monoclonal antibody; against carcinoembryonic antigen (CEA)
Cellular Products:
immunoglobulin; monoclonal antibody; against carcinoembryonic antigen (CEA)
Comments:
Animals were immunized with purified CEA.
Spleen cells were fused with Sp2/0-Ag14 myeloma cells.
The antibody reacts with CEA with an affinity constant of 2.6 X 10 exp10 l/m.
The antibody reacts strongly a variety of human carcinomas and moderately with human colonic polyps.
It cross-reacts weakly with granulocytes.
Complete Growth Medium: Dulbeccos modified Eagles medium with 4 mM L-glutamine adjusted to contain 1.5 g/L sodium bicarbonate and 4.5 g/L glucose and supplemented with 0.01 M HEPES and 0.01 mM 2-mercaptoethanol, 80%; fetal bovine serum, 20%
Subculturing:
Protocol: Cultures can be maintained by the addition of fresh medium or replacement of medium. Alternatively, cultures can be established by centrifugation with subsequent resuspension at 1 to 2 X 10 exp4 viable cells/ml. Maintain cell density between 1 X 10 exp4 and 2 X 10 exp5 viable cells/ml.
Medium Renewal: Add fresh medium every 2 to 3 days (depending on cell density)
Cryopreservation:
Freeze medium: Complete growth medium, 95%; DMSO, 5%
Storage temperature: liquid nitrogen vapor phase
Culture Conditions:
Temperature: 37.0°C
Isotype: IgG1 kappa , IgG1; kappa light chain
Name of Depositor: Beckman Research Center of City of Hope
Deposited As: mouse (B cell); mouse (myeloma)
U.S. Patent Number:
References:

Crawford FG, et al. Specific hybridoma cell line and monoclonal antibodies produced from such specific hybridoma cell line and method of using such monoclonal antibodies to detect carcinoembryonic antigens. US Patent 4,873,313 dated Oct 10 1989

首页 > 产品中心 > 微生物培养 > 菌株 > null > T84.66A3.1A.1F2 [T84.66.A3.1-H-11]

T84.66A3.1A.1F2 [T84.66.A3.1-H-11]

  • 货号: TS210794
  • 好评
询价
  • 品牌 : TESTOBIO
产品名称: T84.66A3.1A.1F2 T84.66.A3.1-H-11
商品货号: TS210794
Organism: Mus musculus (B cell); Mus musculus (myeloma), mouse (B cell); mouse (myeloma)
Cell Type: hybridoma: B lymphocyte
Product Format: frozen
Morphology: lymphoblast
Culture Properties: suspension, with some loosely adherent cells
Biosafety Level: 1

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Disease: Carcinoma
Applications:
The antibody reacts with CEA with an affinity constant of 2.6 X 10 exp10 l/m.
The antibody reacts strongly a variety of human carcinomas and moderately with human colonic polyps.
It cross-reacts weakly with granulocytes.
Storage Conditions: liquid nitrogen vapor phase
Disclosure: This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC.
Derivation:
Animals were immunized with purified CEA.
Spleen cells were fused with Sp2/0-Ag14 myeloma cells.
Genes Expressed:
immunoglobulin; monoclonal antibody; against carcinoembryonic antigen (CEA)
Cellular Products:
immunoglobulin; monoclonal antibody; against carcinoembryonic antigen (CEA)
Comments:
Animals were immunized with purified CEA.
Spleen cells were fused with Sp2/0-Ag14 myeloma cells.
The antibody reacts with CEA with an affinity constant of 2.6 X 10 exp10 l/m.
The antibody reacts strongly a variety of human carcinomas and moderately with human colonic polyps.
It cross-reacts weakly with granulocytes.
Complete Growth Medium: Dulbeccos modified Eagles medium with 4 mM L-glutamine adjusted to contain 1.5 g/L sodium bicarbonate and 4.5 g/L glucose and supplemented with 0.01 M HEPES and 0.01 mM 2-mercaptoethanol, 80%; fetal bovine serum, 20%
Subculturing:
Protocol: Cultures can be maintained by the addition of fresh medium or replacement of medium. Alternatively, cultures can be established by centrifugation with subsequent resuspension at 1 to 2 X 10 exp4 viable cells/ml. Maintain cell density between 1 X 10 exp4 and 2 X 10 exp5 viable cells/ml.
Medium Renewal: Add fresh medium every 2 to 3 days (depending on cell density)
Cryopreservation:
Freeze medium: Complete growth medium, 95%; DMSO, 5%
Storage temperature: liquid nitrogen vapor phase
Culture Conditions:
Temperature: 37.0°C
Isotype: IgG1 kappa , IgG1; kappa light chain
Name of Depositor: Beckman Research Center of City of Hope
Deposited As: mouse (B cell); mouse (myeloma)
U.S. Patent Number:
References:

Crawford FG, et al. Specific hybridoma cell line and monoclonal antibodies produced from such specific hybridoma cell line and method of using such monoclonal antibodies to detect carcinoembryonic antigens. US Patent 4,873,313 dated Oct 10 1989

合作单位: